Atriva takes MEK inhibitor into phase 2 for COVID-19

Atriva Therapeutics is starting a phase 2 trial of its MEK inhibitor ATR-002 in patients with coronavirus infections, saying the drug could help prevent patients progressing to

Coronavirus news roundup 09/04/2020

As the number of coronavirus cases in the world exceeds 1.4 million, the pharma industry is pushing to find new drugs, therapies and tests in the effort to bring the pandemic under control.

Synairgen doses first patients with COVID-19 drug

Celltrion to develop coronavirus antibody and fast test

South Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working on an antibody-based antiviral and a self-testing diagnosis kit